GovChime
AWARDDELIVERY ORDEROther than small business

Delivery order 75N91020F00009LEIDOS BIOMEDICAL RESEARCH INC

Overview

Award facts

Net obligations
$89.56M
$89,563,956of $136.72M potential value
Outlays (paid to date)
$65.00M
$65.00M paid of $89.56M obligated$65,004,110
Period of performance
Apr 1, 2020 to Jul 31, 2028
Ends in 20 months
Modifications
12
Latest action Sep 29, 2025
Contract type
Delivery order
PIID 75N91020F00009

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

ON BEHALF OF NIAID-DCR, FACILITATE THE CONDUCT OF TWO, RANDOMIZED TRIALS AS DETAILED BELOW IN I AND II: I. A RANDOMIZED BLINDED CONTROLLED TRIAL OF THE SAFETY AND EFFICACY OF INVESTIGATIONAL THERAPEUTICS FOR THE TREATMENT OF COVID-19 (2,000 SUBJECTS

Dates and value

Award date
Signed on Apr 1, 2020
Potential end of performance
Jul 30, 2028
Current value
$89,563,956Base and exercised options
Potential value (if all options are exercised)
$136,722,003
Parent contract vehicle
75N91019D00024 (IDC, single award) — 185 orders recorded under it

Obligations by fiscal year of action

  • FY2025: $5,946,332
  • FY2024: $13,721,004
  • FY2022: $2,536,808
  • FY2020: $67,359,812

Total across 4 fiscal years: $89,563,956

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Sep 29, 2025. View on USAspending · Recipient on SAM.gov

Recipient

LocationFREDERICK, MD
UEIHV8BH9BPG8Y9
CAGE code3LYK6
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyLEIDOS HOLDINGS, INC.

Business types and certifications

For-profit organizationCorporation (not tax-exempt)

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
National institute of allergy and infectious diseases (0885)Program activities075-0140, 075-0849, 075-0885Federal accounts (agency financial reports)

Place of performance

Place of performance
Frederick, Maryland 21702-9242
Congressional district (place of performance)
MD-06As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
Not reported
Contract pricing
Cost plus fixed feeU

Contract details

Subcontracting plan
Individual subcontract planF
Certified cost or pricing data
Yes
Service Contract Act labor standards
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Apr 1, 2020Base obligation at award: $33,571,749
Latest action
Sep 29, 2025 — Other administrative actionModification P00012; obligation change +$5,946,332; administrative: no change in scope or value
Latest substantive action
Apr 24, 2025 — Terminated for convenienceModification P00011
Latest funding action
Apr 21, 2022 — Funding onlyModification P00006; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Other administrative action8
  • Funding only1
  • Terminated for convenience1
  • Option exercised1
  • Letter contract definitized1
13 actions recorded, Apr 1, 2020 to Sep 29, 2025; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
$5,946,332
Latest action: change in base and all options
$5,946,332

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
Environmentally preferableF
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Delivery orderC
Parent vehicle type
IDCB
Parent vehicle: multiple or single award
Single awardS
Parent vehicle agency
National Institutes Of Health7529
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N910
Transactions recorded under this award key
13

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2020/2024-0885-000
  • 075-2022/2022-0849-000
  • 075-2024/2024-0849-000
  • 075-2024/2024-0885-000
  • 075-2025/2025-0885-000
  • 075-X-0140-000
Object classes
  • 25.2: Other services from non-Federal sources
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • L: Emergency P.L. 116-123
  • N: Emergency P.L. 116-136
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
  • V: Non-emergency P.L. 117-2
COVID-19 supplemental obligations
$69,896,620
COVID-19 supplemental outlays
$64,965,773